The Indian Pharmaceutical industry plays a vital role in promoting and sustaining development in the field of global medicine.
Indian Pharmaceutical industry is valued at USD12 billion in 2013 and is expected to grow to USD 55 billion by 2020.
2. Indian Pharma Sector Outlook
ď¨ The Indian Pharmaceutical
industry plays a vital role in
promoting and sustaining
development in the field of
global medicine.
ď¨ Indian Pharmaceutical
industry is valued at
USD12 billion in 2013 and
is expected to grow to USD
55 billion by 2020.
Globally, India ranks 3rd in
terms of volume and 14th in
terms of value.
Source: PwC, Mckinsey, TechSci Reseach. Notes: F-Forecast, CAGR- Compound Annual Growth Rate, E- Estimated
3. ď¨ The Indian pharmaceuticals market increased at a
CAGR of 12.79 per cent in 2015 from USD 6 billion in
2005, and is expected to expand at a CAGR of 15.92
per cent to USD 55 billion by 2020
ď¨ By 2020, India is likely to be among the top three
pharmaceutical markets by incremental growth and sixth
largest market globally in absolute size
ď¨ Indiaâs cost of production is significantly lower than that
of the US and almost half of that of Europe. It gives a
competitive edge to India over others.
Continued..
4. ď¨ Pharmaceutical sales,
as a percentage of total
healthcare spending,
are expected to
increase to 27 per cent
by 2016 from 18.9 per
cent in 2008.
Growth expected in expenditure
6. Pharma Sector Mutual Fund
ď¨ What are they ?
ď Pharma Sector funds are equity oriented
schemes investing predominantly in pharma
stocks.
ď¨ Who should invest?
ď High risk profile investors who are well-versed
with stock market and understands the sector.
7. Growth of Pharma sector funds
Pharma sector funds have been key performers in the last one year, which is clearly
evident from the rise in AUM of about 68% in just 1 year (Mar 2014- Mar-2015)
9. SIP Returns
SIP returns on monthly investment of Rs. 10,000/-
Source: Ace MF, Data as on 05th November 2015
10. Sector wise and Company wise exposure
Source: Ace MF, Data as on September, 2015
11. Taxation
ďą Pharma Sector funds are equity-oriented funds
and hence it is treated same as equity for
taxation purpose.
ďą Dividend income is tax free.
ďą Long term capital gains (holding period of one
year and above) are tax free and Short term
capital gains (holding period of less than a
year) are tax at 15%.
12. Time is ticking and every second countsâŚ.START
INVESTING NOWâŚ.ITS NEVER TOO LATE !!
Thank you!
Email: mfcustomercare@ventura1.com
Phone: +91 22 6754 7046 / 6774 7577